Dr. Dr. Elisabeth Roider

Dr. Elisabeth Roider is a physician-scientist, entrepreneur, and investor at the forefront of preventive and longevity medicine. She is the Strategic and Medical Advisor to the Nescens Clinique (Switzerland), a leading institution in longevity and preventive medicine. In this role, she contributes to the development of next-generation medical programs, combining integrative medicine, advanced diagnostics, and international healthcare expertise to optimize healthspan through personalized, science-driven care.

Alongside her advisory role at Nescens, Elisabeth holds academic leadership positions at Harvard and the University of Basel, where she leads translational research in pigmentation biology, mitochondrial resilience, RNA therapeutics, and the health economics of prevention. Her work bridges basic science and clinical application and has resulted in patents, high-impact publications in journals such as Cell, Nature, and The Lancet, and novel clinical insights, including the first detection of SARS-CoV-2 in skin.

Clinically trained at Harvard Medical School, the University of Basel, and the University of St. Gallen, she maintains her medical practice as a board-certified dermatologist and has over 15 years of experience across dermatology, oncology, immunology, and longevity medicine.

From 2022 to 2025 she was Partner and Chief Scientific and Medical Officer at Maximon, one of the first longevity venture studios, and previously invested via the Longevity Co-Investment Fund in the field of consumer health, including nutraceuticals, multi-omics diagnostics, and longevity clinics.

Today, she leads InnoMed Advisors, where she supports corporations and funds with scientific and medical due diligence, strategic advisory, and the design of innovative clinical programs. She is also founder of EMR BioHealth, a next-generation skincare biotech company focused on molecular approaches to skin longevity.

Across academia, clinic, and industry, Elisabeth bridges science, medicine, and capital to translate cutting-edge research into scalable innovations that extend healthspan.

On 11 March 2026 she spoke at "The Long Game: Zurich Health Night @Google" at Google Zurich, an evening on code, biology and healthcare organised by Longevity Switzerland together with GDGoC Zurich.